Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
– Sell
-26,932
Closed -$737K – 856
2017
Q1
$737K Sell
26,932
-5,518
-17% -$141K 0.04% 505
2016
Q4
$800K Sell
32,450
-5,107
-14% -$108K 0.05% 421
2016
Q3
$851K Sell
37,557
-3,677
-9% -$80.3K 0.04% 542
2016
Q2
$780K Buy
41,234
+17,975
+77% +$375K 0.03% 551
2016
Q1
$608K Buy
23,259
+3,362
+17% +$77.8K 0.04% 572
2015
Q4
$513K Buy
19,897
+25
+0.1% +$675 0.04% 509
2015
Q3
$447K Buy
19,872
+9,655
+94% +$248K 0.04% 463
2015
Q2
$305K Buy
+10,217
New +$288K 0.04% 471
2015
Q1
– Sell
-9,471
Closed -$211K – 603
2014
Q4
$211K Buy
+9,471
New +$225K 0.07% 415

Other funds holding TBI

Clinton Group's TBI Position: Q2 2017 in Review

Clinton Group sold out of Trueblue (TBI) in Q2 2017, closing a stake of 26,932 shares — an estimated $737K sold.

Clinton Group first reported a position in TBI in Q4 2014 and held it in 9 quarters. The position peaked at $851K in Q3 2016. 193 funds tracked by Wall St. Rank hold TBI as of Q2 2017.

  • Clinton Group reported no remaining Trueblue position as of Q2 2017 after selling out during the quarter.
  • Clinton Group sold 26,932 Trueblue shares in Q2 2017, an estimated $737K.
  • Clinton Group first reported a position in Trueblue in Q4 2014 and held it in 9 quarters.
  • Clinton Group's Trueblue position peaked at $851K in Q3 2016.
  • 193 funds tracked by Wall St. Rank held Trueblue as of Q2 2017.

Based on Clinton Group's 13F filing for Q2 2017, filed 14 Aug 2017.